Switching treatments in haemophilia: is there a risk of inhibitor development?

Patients with haemophilia A (and their physicians) may be reluctant to switch factor VIII (FVIII) concentrates, often due to concerns about increasing the risk of inhibitors; this reluctance to switch may contribute to patients missing the clinical benefits provided by the arrival of new factor VIII...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur J Haematol
Main Authors: Santagostino, Elena, Auerswald, Günter, Benson, Gary, Dolan, Gerry, Jiménez-Yuste, Victor, Lambert, Thierry, Ljung, Rolf, Morfini, Massimo, Remor, Eduardo, Zupančić Šalek, Silva
Format: Artigo
Sprog:Inglês
Udgivet: BlackWell Publishing Ltd 2015
Fag:
Review Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4407931/
https://ncbi.nlm.nih.gov/pubmed/25135593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ejh.12433
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker